Suppression of immediate skin tests by ranitidine

Area of Science:

• Pharmacology
• Dermatology
• Allergy Research

Background:

• Immediate skin reactions are key indicators in allergy diagnostics.
• Histamine and compound 48/80 are commonly used to elicit these reactions.
• Ranitidine is a histamine H2-receptor antagonist.

Purpose of the Study:

• To evaluate the efficacy of ranitidine in suppressing immediate skin reactions.
• To compare the effects of ranitidine on histamine-induced versus compound 48/80-induced responses.
• To assess the clinical significance of ranitidine's effects in allergy testing.

Main Methods:

• A double-blind, placebo-controlled study was conducted.
• Twenty-three subjects received ranitidine (150 mg every 12 hours for seven doses) or placebo.
• Skin reactions (wheal-and-flare) to histamine and compound 48/80 were measured.

Main Results:

• Ranitidine demonstrated a statistically significant 22% suppression of the histamine wheal-and-flare response (p < 0.05).
• Ranitidine showed only a 4% suppression of the compound 48/80 wheal-and-flare response, which was not statistically significant.
• The degree of histamine suppression may have limited clinical relevance.

Conclusions:

• Ranitidine effectively suppresses histamine-induced skin reactions.
• Ranitidine has minimal impact on compound 48/80-induced skin reactions.
• The clinical utility of ranitidine for allergy diagnostic testing appears limited.